ERK1-based pathway as a new selective mechanism to modulate CCR5 with natural antibodies

Assunta Venuti, Claudia Pastori, Gabriel Siracusano, Agostino Riva, Maria Teresa Sciortino, Lucia Lopalco

Research output: Contribution to journalArticlepeer-review


Natural human Abs, recognizing an epitope within the first extramembrane loop of CCR5 (the main HIV coreceptor), induce a longlasting internalization (48 h) of the protein, whereas all known CCR5 modulating molecules show a short-term kinetics (60-90 min). Despite extensive studies on the regulation of CCR5 signaling cascades, which are the effect of concomitant CCR5 internalization by exogenous stimuli such as Abs, downstream signaling continues to be poorly understood. In this article, we report a hitherto unrecognized mechanism of CCR5 modulation mediated by G protein-dependent ERK1 activity. We further demonstrate that ERK1 is localized mainly in the cytoplasmic compartment and that it interacts directly with the CCR5 protein, thus provoking possible CCR5 degradation with a subsequent de novo synthesis, and that re-expression of CCR5 on the cell membrane required several days. In contrast, the RANTES treatment induces a recovery of the receptor on the cell membrane in short-term kinetics without the involvement of de novo protein synthesis. The said new pathway could be relevant not only to better understand the molecular basis of all pathologic conditions in which CCR5 is involved but also to generate new tools to block viral infections, such as the use of recombinant Abs.

Original languageEnglish
Pages (from-to)3045-3057
Number of pages13
JournalJournal of Immunology
Issue number7
Publication statusPublished - Oct 1 2015

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)


Dive into the research topics of 'ERK1-based pathway as a new selective mechanism to modulate CCR5 with natural antibodies'. Together they form a unique fingerprint.

Cite this